Compare Samsara Inc (IOT) vs Johnson & Johnson (JNJ) Price & Performance

Samsara (IOT) trades at $39.11, down 1.88% on the day, with strong technical momentum as moving averages signal bullish sentiment. The company shows impressive revenue growth, projecting $1.7B for 2026 with a positive net income turnaround to $58M. Recent earnings beats and a 'Moderate Buy' analyst consensus with a $44.50 price target highlight investor confidence in the Connected Operations Platform strategy.

Outlook remains positive with 36.9% upside potential to consensus targets, though elevated P/E ratio of 403.2 and negative 2025 EBITDA pose valuation risks. Key catalysts include continued AI adoption in physical operations and September earnings report, while competition and execution on growth investments represent primary challenges.

Johnson & Johnson (JNJ) trades at $261.26, down 0.21% on the day, near its 52-week high. The stock shows a bullish technical trend with strong moving averages and recent earnings beats. Revenue grew to $94.19B in 2025, with a net income margin of 21.48%, though cash flow turned negative due to heavy investing. The company maintains a robust dividend history, with consistent payouts and a 64-year growth streak.

Outlook remains positive with a consensus price target of $284.50, offering ~9% upside. Risks include legal headwinds and patent expirations, but analyst sentiment is bullish (52.5% buy ratings). JNJ's defensive profile and pipeline strength support long-term growth, though investors should monitor debt levels, which rose to 24.06% of assets in 2025.